Abstract:Background: The timely diagnosis of tuberculosis through innovative biomarkers that do not rely on sputum samples is a primary focus for strategies aimed at eradicating tuberculosis. miR-29 is an important regulator of tuberculosis pathogenesis. Its differential expression pattern in healthy, latent, and active people who develop tuberculosis has revealed its potential as a biomarker in recent studies. Therefore, a systematic review and meta-analysis were performed for the role of miR-29 in the diagnosis of tuberculosis. Methods: EMBASE, PubMed, CNKI, Web of Science, and Cochrane Library databases were searched utilizing predefined keywords for literature published from 2000 to February 2024.Included in the analysis were studies reporting on the accuracy of miR-29 in the diagnosis of tuberculosis, while articles assessing other small RNAs were not considered. All types of study designs, including case–control, cross-sectional, and cohort studies, were included, whether prospectively or retrospectively sampled, and the quality of included studies was determined utilizing the QUADAS-2 tool. Publication bias was analyzed via the construction of funnel plots. Heterogeneity among studies and summary results for specificity, sensitivity, and diagnostic odds ratio (DOR) are depicted in forest plots. Results: A total of 227 studies were acquired from the various databases, and 18 articles were selected for quantitative analysis. These articles encompassed a total of 2,825 subjects, primarily sourced from the Asian region. Patient specimens, including sputum, peripheral blood mononuclear cells, cerebrospinal fluid and serum/plasma samples, were collected upon admission and during hospitalization for tuberculosis testing. miR-29a had an overall sensitivity of 82% (95% CI 77, 85%) and an overall specificity of 82% (95% CI 78, 86%) for detecting tuberculosis. DOR was 21 (95% CI 16–28), and the area under the curve was 0.89 (95% CI 0.86, 0.91). miR-29a had slightly different diagnostic efficacy in different specimens. miR-29a showed good performance in both the diagnosis of pulmonary tuberculosis and extrapulmonary tuberculosis. miR-29b and miR-29c also had a good performance in diagnosis of tuberculosis. Conclusion: As can be seen from the diagnostic performance of miR-29, miR-29 can be used as a potential biomarker for the rapid detection of tuberculosis. Systematic Review Registration: https://www.crd.york.ac.uk/PROSPERO/display_record.php?RecordID=461107.

A systematic review and meta-analysis of circulating serum and plasma microRNAs in TB diagnosis

Diagnostic performance of microRNA-29a in active pulmonary tuberculosis: a systematic review and meta-analysis

miR-29 as diagnostic biomarkers for tuberculosis: a systematic review and meta-analysis

Diagnostic Value of MicroRNAs in Active Tuberculosis based on Meta-analysis and Enrichment Analyses

miRNAs in Tuberculosis: New Avenues for Diagnosis and Host-Directed Therapy

Biomarkers in diagnosing and therapeutic monitoring of tuberculosis: a review

A Systematic Review of Biomarkers in Spinal Tuberculosis

Identifying quantitative sncRNAs signature using global sequencing as a potential biomarker for tuberculosis diagnosis and their role in regulating host response

Screening And Identification Of Six Serum Micrornas As Novel Potential Combination Biomarkers For Pulmonary Tuberculosis Diagnosis

Characterization Of A Novel Panel Of Plasma Micrornas That Discriminates Between Mycobacterium Tuberculosis Infection And Healthy Individuals

Profiling the Mrna and Mirna in Peripheral Blood Mononuclear Cells in Subjects with Active Tuberculosis

The role of Mycobacterium tuberculosis exosomal miRNAs in host pathogen cross-talk as diagnostic and therapeutic biomarkers

Circulating MicroRNAs as Biomarkers for the Early Diagnosis of Lung Cancer and Its Differentiation from Tuberculosis

Active versus latent pulmonary tuberculosis: which one is the appropriate distinguishing biomarker?

MiRNA-155 and Mirna-132 As Potential Diagnostic Biomarkers for Pulmonary Tuberculosis: A Preliminary Study.

Single molecule measurements of microRNAs in the serum of patients with pulmonary tuberculosis

A Review Of Host-Specific Diagnostic And Surrogate Biomarkers In Children With Pulmonary Tuberculosis

Proteomics-based host-specific biomarkers for tuberculosis: The future of TB diagnosis

Biomarkers Correlated with Tuberculosis Preventive Treatment Response: A Systematic Review and Meta-Analysis

The potential of circulating microRNAs as novel diagnostic biomarkers of COVID-19: a systematic review and meta-analysis

Host blood protein biomarkers to screen for Tuberculosis disease: a systematic review and meta-analysis